Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. scores highest on Torque (96) and lowest on Price (0). Its PosiPenta is 42.59 out of 100, around the middle of similar companies.
On the Penta Grid this week, Armata Pharmaceuticals, Inc. is Grid #450 of 837 in the Healthcare sector in United States, and Grid #2,635 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Armata Pharmaceuticals, Inc. | 42.59 | 0 | 38 | 24 | 96 | 54 |
| TuHURA Biosciences, Inc. | 38.49 | 11 | 40 | 59 | 25 | 58 |
| Retension Pharmaceuticals, Inc. | 52.19 | 0 | 27 | 93 | 88 | 54 |
| Cumberland Pharmaceuticals Inc. | 57.38 | 11 | 72 | 83 | 53 | 68 |
| Anavex Life Sciences Corp. | 40.51 | 38 | 37 | 9 | 79 | 39 |
| Health Catalyst, Inc. | 39.73 | 36 | 50 | 51 | 18 | 44 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.64 |
| P/B ratio | -0.40 |
EEarnings
| Trailing EPS | ₹-501.04 |
| Forward EPS | ₹-193.22 |
NNitro
| Price | 319.19 |
| 52-week high | 1547.64 |
| 52-week low | 260.47 |
| Fall from 52-week high | 79.4% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -1.32 |
AAnchor
| Beta (price swings) | 1.41 |
| Market cap | ₹1,186 Cr |
| Insider holding | 67.64% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Armata Pharmaceuticals, Inc.'s PosiPenta score?
Armata Pharmaceuticals, Inc.'s PosiPenta is 42.59 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Armata Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Armata Pharmaceuticals, Inc. is Grid #450 of 837 in the Healthcare sector in United States, and Grid #2,635 of 4,000 in United States.
Which PosiPenta pillar is strongest for Armata Pharmaceuticals, Inc.?
Torque (durability), with a score of 96 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Armata Pharmaceuticals, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Armata Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 5.59 points, from 37.00 to 42.59.
PositoAI is for research and education only and is not investment advice.